News and Events - Precision Biologics

12MarMarch 12, 2026

Precision Biologics, Inc. CEO to present at the online Antibody-Drug Conjugates MicroSummit conference, March 17th, 2026.

Philip M. Arlen, M.D., will present an online talk at the third and last session...

08MarMarch 8, 2026

Precision Biologics' approach is the subject of an article in the current issue of trade...

02MarMarch 2, 2026

Precision Biologics, Inc. CEO Philip M. Arlen, MD, will give a presentation on monoclonal antibodies...

17FebFebruary 17, 2026

Precision Biologics, Inc. CEO Philip M Arlen, MD will give a Keynote speech and present...

05NovNovember 5, 2025

BETHESDA, Md., Nov. 5, 2025 /PRNewswire/ -- Precision Biologics, Inc. announces in vitro and in vivo efficacy of its novel...

19SepSeptember 19, 2025

BETHESDA, Md., Sept. 19, 2025 /PRNewswire/ -- Precision Biologics, Inc. reports that in vitro and in vivo...

25AprApril 25, 2025

Precision Biologics, Inc. will present new data on a newly developed Antibody-Drug Conjugate PB-223 ADC...

18AprApril 18, 2025

Precision Biologics, Inc. CEO Philip M Arlen, MD will give the Keynote speech, and also...

18AprApril 18, 2025

An article titled “Cancer Vaccines-Improving Their Aim” in the current April 2025 issue of trade...

07MarMarch 7, 2025

Precision Biologics announces that our Chief Scientific Officer, Kwong "Al" Tsang, will deliver a talk...